Kenmerk
Dental cavities
Klinische naam: Carious teeth
Caries is a multifactorial bacterial infection affecting the structure of the tooth. This term has been used to describe the presence of more than expected dental caries.
Samenvatting
- Ook bekend als
- Dental decay, Rotting teeth, Tooth cavities, Tooth decay, Caries, Cariosity of teeth, Dental caries, Early dental caries, Frequent caries
- Lichaamssysteem
- Abnormality of head or neck
Deze pagina als gegevens
Voeg .json toe aan het adres van de pagina, of vraag application/json aan, om haar als JSON te lezen.
library(jsonlite)
url <- "https://dantelabs.com/traits/carious-teeth.json"
page <- fromJSON(url)
page$trait$nameLees de genen die aan Dental cavities gekoppeld zijn, en de rest van uw genoom, met één test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen171 genen gekoppeld aan Dental cavities
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Dental cavities voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| AP3B1adaptor related protein complex 3 subunit beta 1 | Altijd | In 1 aandoening |
| COL17A1collagen type XVII alpha 1 chain | Altijd | In 3 aandoeningen |
| FGF10fibroblast growth factor 10 | Altijd | In 3 aandoeningen |
| FGFR3fibroblast growth factor receptor 3 | Altijd | In 2 aandoeningen |
| IFT52intraflagellar transport 52 | Altijd | In 1 aandoening |
| IKZF2IKAROS family zinc finger 2 | Altijd | In 1 aandoening |
| LAMB3laminin subunit beta 3 | Altijd | In 2 aandoeningen |
| LIFRLIF receptor subunit alpha | Altijd | In 1 aandoening |
| PAX1paired box 1 | Altijd | In 1 aandoening |
| RBM28RNA binding motif protein 28 | Altijd | In 2 aandoeningen |
| RBSNrabenosyn, RAB effector | Altijd | In 1 aandoening |
| SEC23ASEC23 homolog A, COPII component | Altijd | In 2 aandoeningen |
| SLC24A4solute carrier family 24 member 4 | Altijd | In 1 aandoening |
| THOC6THO complex subunit 6 | Altijd | In 2 aandoeningen |
| TP63tumor protein p63 | Altijd | In 3 aandoeningen |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Altijd | In 2 aandoeningen |
| ATP6V0A2ATPase H+ transporting V0 subunit a2 | Heel vaak (80–99%) | In 4 aandoeningen |
| ATP6V1AATPase H+ transporting V1 subunit A | Heel vaak (80–99%) | In 1 aandoening |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Heel vaak (80–99%) | In 1 aandoening |
| CDH11cadherin 11 | Heel vaak (80–99%) | In 1 aandoening |
| CNNM4cyclin and CBS domain divalent metal cation transport mediator 4 | Heel vaak (80–99%) | In 1 aandoening |
| COL7A1collagen type VII alpha 1 chain | Heel vaak (80–99%) | In 5 aandoeningen |
| FGF3fibroblast growth factor 3 | Heel vaak (80–99%) | In 1 aandoening |
| GJA1gap junction protein alpha 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| IFIH1interferon induced with helicase C domain 1 | Heel vaak (80–99%) | In 1 aandoening |
| MMP1matrix metallopeptidase 1 | Heel vaak (80–99%) | In 1 aandoening |
| PEPDpeptidase D | Heel vaak (80–99%) | In 1 aandoening |
| RUNX2RUNX family transcription factor 2 | Heel vaak (80–99%) | In 1 aandoening |
| ACDACD shelterin complex subunit and telomerase recruitment factor | Vaak (30–79%) | In 1 aandoening |
| AGAaspartylglucosaminidase | Vaak (30–79%) | In 1 aandoening |
| ARSBarylsulfatase B | Vaak (30–79%) | In 1 aandoening |
| ARVCFARVCF delta catenin family member | Vaak (30–79%) | In 1 aandoening |
| ATRATR checkpoint kinase | Vaak (30–79%) | In 1 aandoening |
| CAV1caveolin 1 | Vaak (30–79%) | In 1 aandoening |
| CCN2cellular communication network factor 2 | Vaak (30–79%) | In 1 aandoening |
| CCR6C-C motif chemokine receptor 6 | Vaak (30–79%) | In 1 aandoening |
| CDH1cadherin 1 | Vaak (30–79%) | In 1 aandoening |
| CDH3cadherin 3 | Vaak (30–79%) | In 1 aandoening |
| COG6component of oligomeric golgi complex 6 | Vaak (30–79%) | In 2 aandoeningen |
| COMTcatechol-O-methyltransferase | Vaak (30–79%) | In 1 aandoening |
Toon nog 131 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| COX4I2cytochrome c oxidase subunit 4I2 | Vaak (30–79%) | In 1 aandoening |
| CTC1CST telomere replication complex component 1 | Vaak (30–79%) | In 1 aandoening |
| CTNND1catenin delta 1 | Vaak (30–79%) | In 1 aandoening |
| CTSCcathepsin C | Vaak (30–79%) | In 1 aandoening |
| DKC1dyskerin pseudouridine synthase 1 | Vaak (30–79%) | In 2 aandoeningen |
| DPH5diphthamide biosynthesis 5 | Vaak (30–79%) | In 1 aandoening |
| EP300EP300 lysine acetyltransferase | Vaak (30–79%) | In 2 aandoeningen |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Vaak (30–79%) | In 3 aandoeningen |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Vaak (30–79%) | In 2 aandoeningen |
| FAM111AFAM111 trypsin like peptidase A | Vaak (30–79%) | In 1 aandoening |
| FERMT1FERM domain containing kindlin 1 | Vaak (30–79%) | In 2 aandoeningen |
| FGFR2fibroblast growth factor receptor 2 | Vaak (30–79%) | In 2 aandoeningen |
| GP1BBglycoprotein Ib platelet subunit beta | Vaak (30–79%) | In 1 aandoening |
| GTF2H5general transcription factor IIH subunit 5 | Vaak (30–79%) | In 2 aandoeningen |
| HIRAhistone cell cycle regulator | Vaak (30–79%) | In 1 aandoening |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Vaak (30–79%) | In 1 aandoening |
| IRF5interferon regulatory factor 5 | Vaak (30–79%) | In 1 aandoening |
| JMJD1Cjumonji domain containing 1C | Vaak (30–79%) | In 1 aandoening |
| LAMA3laminin subunit alpha 3 | Vaak (30–79%) | In 2 aandoeningen |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Vaak (30–79%) | In 1 aandoening |
| MMP13matrix metallopeptidase 13 | Vaak (30–79%) | In 1 aandoening |
| NECTIN1nectin cell adhesion molecule 1 | Vaak (30–79%) | In 1 aandoening |
| NHP2NHP2 ribonucleoprotein | Vaak (30–79%) | In 2 aandoeningen |
| NOP10NOP10 ribonucleoprotein | Vaak (30–79%) | In 2 aandoeningen |
| NPM1nucleophosmin 1 | Vaak (30–79%) | In 1 aandoening |
| PARNpoly(A)-specific ribonuclease | Vaak (30–79%) | In 2 aandoeningen |
| PERPp53 apoptosis effector related to PMP22 | Vaak (30–79%) | In 1 aandoening |
| PGM2L1phosphoglucomutase 2 like 1 | Vaak (30–79%) | In 1 aandoening |
| RREB1ras responsive element binding protein 1 | Vaak (30–79%) | In 1 aandoening |
| RTEL1regulator of telomere elongation helicase 1 | Vaak (30–79%) | In 1 aandoening |
| SEC24CSEC24 homolog C, COPII component | Vaak (30–79%) | In 1 aandoening |
| SFRP4secreted frizzled related protein 4 | Vaak (30–79%) | In 2 aandoeningen |
| SLC10A7solute carrier family 10 member 7 | Vaak (30–79%) | In 1 aandoening |
| SRCAPSnf2 related CREBBP activator protein | Vaak (30–79%) | In 2 aandoeningen |
| TBCEtubulin folding cofactor E | Vaak (30–79%) | In 2 aandoeningen |
| TBX1T-box transcription factor 1 | Vaak (30–79%) | In 1 aandoening |
| TERCtelomerase RNA component | Vaak (30–79%) | In 2 aandoeningen |
| TERTtelomerase reverse transcriptase | Vaak (30–79%) | In 2 aandoeningen |
| TINF2TERF1 interacting nuclear factor 2 | Vaak (30–79%) | In 2 aandoeningen |
| TRPV3transient receptor potential cation channel subfamily V member 3 | Vaak (30–79%) | In 1 aandoening |
| TYMSthymidylate synthetase | Vaak (30–79%) | In 1 aandoening |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Vaak (30–79%) | In 1 aandoening |
| WRAP53WD repeat containing antisense to TP53 | Vaak (30–79%) | In 1 aandoening |
| AARS1alanyl-tRNA synthetase 1 | Soms (5–29%) | In 1 aandoening |
| ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase | Soms (5–29%) | In 1 aandoening |
| ADNPactivity dependent neuroprotector homeobox | Soms (5–29%) | In 1 aandoening |
| AKT1AKT serine/threonine kinase 1 | Soms (5–29%) | In 1 aandoening |
| ANAPC1anaphase promoting complex subunit 1 | Soms (5–29%) | In 1 aandoening |
| APCAPC regulator of Wnt signaling pathway | Soms (5–29%) | In 1 aandoening |
| ASLargininosuccinate lyase | Soms (5–29%) | In 1 aandoening |
| B3GALT6beta-1,3-galactosyltransferase 6 | Soms (5–29%) | In 1 aandoening |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Soms (5–29%) | In 1 aandoening |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Soms (5–29%) | In 1 aandoening |
| CARS1cysteinyl-tRNA synthetase 1 | Soms (5–29%) | In 1 aandoening |
| CLCN7Cl-/H+ antiporter 7 | Soms (5–29%) | In 1 aandoening |
| CLIP2CAP-Gly domain containing linker protein 2 | Soms (5–29%) | In 1 aandoening |
| COL2A1collagen type II alpha 1 chain | Soms (5–29%) | In 1 aandoening |
| CREBBPCREB binding lysine acetyltransferase | Soms (5–29%) | In 2 aandoeningen |
| CTSKcathepsin K | Soms (5–29%) | In 2 aandoeningen |
| DBR1debranching RNA lariats 1 | Soms (5–29%) | In 1 aandoening |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Soms (5–29%) | In 1 aandoening |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Soms (5–29%) | In 1 aandoening |
| EFL1elongation factor like GTPase 1 | Soms (5–29%) | In 1 aandoening |
| EIF4Heukaryotic translation initiation factor 4H | Soms (5–29%) | In 1 aandoening |
| ELNelastin | Soms (5–29%) | In 1 aandoening |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Soms (5–29%) | In 1 aandoening |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Soms (5–29%) | In 1 aandoening |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Soms (5–29%) | In 1 aandoening |
| GTF2E2general transcription factor IIE subunit 2 | Soms (5–29%) | In 1 aandoening |
| GTF2Igeneral transcription factor IIi | Soms (5–29%) | In 1 aandoening |
| GTF2IRD1GTF2I repeat domain containing 1 | Soms (5–29%) | In 1 aandoening |
| GTF2IRD2GTF2I repeat domain containing 2 | Soms (5–29%) | In 1 aandoening |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Soms (5–29%) | In 1 aandoening |
| KDM5Alysine demethylase 5A | Soms (5–29%) | In 1 aandoening |
| KMT2Dlysine methyltransferase 2D | Soms (5–29%) | In 1 aandoening |
| KRT14keratin 14 | Soms (5–29%) | In 2 aandoeningen |
| LIMK1LIM domain kinase 1 | Soms (5–29%) | In 1 aandoening |
| MAGEL2MAGE family member L2 | Soms (5–29%) | In 1 aandoening |
| MEGF8multiple EGF like domains 8 | Soms (5–29%) | In 1 aandoening |
| METTL27methyltransferase like 27 | Soms (5–29%) | In 1 aandoening |
| MKRN3makorin ring finger protein 3 | Soms (5–29%) | In 1 aandoening |
| MPLKIPM-phase specific PLK1 interacting protein | Soms (5–29%) | In 1 aandoening |
| NCF1neutrophil cytosolic factor 1 | Soms (5–29%) | In 1 aandoening |
| NPAP1nuclear pore associated protein 1 | Soms (5–29%) | In 1 aandoening |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Soms (5–29%) | In 1 aandoening |
| PKP1plakophilin 1 | Soms (5–29%) | In 1 aandoening |
| PPP1CBprotein phosphatase 1 catalytic subunit beta | Soms (5–29%) | In 1 aandoening |
| PTCH1patched 1 | Soms (5–29%) | In 1 aandoening |
| PTCH2patched 2 | Soms (5–29%) | In 1 aandoening |
| PWAR1Prader Willi/Angelman region RNA 1 | Soms (5–29%) | In 1 aandoening |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Soms (5–29%) | In 1 aandoening |
| RECQL4RecQ like helicase 4 | Soms (5–29%) | In 1 aandoening |
| RFC2replication factor C subunit 2 | Soms (5–29%) | In 1 aandoening |
| RNF113Aring finger protein 113A | Soms (5–29%) | In 1 aandoening |
| SATB1SATB homeobox 1 | Soms (5–29%) | In 1 aandoening |
| SBDSSBDS ribosome maturation factor | Soms (5–29%) | In 1 aandoening |
| SCNM1sodium channel modifier 1 | Soms (5–29%) | In 1 aandoening |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Soms (5–29%) | In 1 aandoening |
| SLC19A1solute carrier family 19 member 1 | Soms (5–29%) | In 1 aandoening |
| SLC37A4solute carrier family 37 member 4 | Soms (5–29%) | In 1 aandoening |
| SLF2SMC5/6 complex localization factor 2 | Soms (5–29%) | In 1 aandoening |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Soms (5–29%) | In 1 aandoening |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Soms (5–29%) | In 1 aandoening |
| SNRPBsmall nuclear ribonucleoprotein polypeptides B and B1 | Soms (5–29%) | In 1 aandoening |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Soms (5–29%) | In 1 aandoening |
| SOX9SRY-box transcription factor 9 | Soms (5–29%) | In 1 aandoening |
| STX1Asyntaxin 1A | Soms (5–29%) | In 1 aandoening |
| SUFUSUFU negative regulator of hedgehog signaling | Soms (5–29%) | In 1 aandoening |
| TARS1threonyl-tRNA synthetase 1 | Soms (5–29%) | In 1 aandoening |
| TBL2transducin beta like 2 | Soms (5–29%) | In 1 aandoening |
| TGFB1transforming growth factor beta 1 | Soms (5–29%) | In 2 aandoeningen |
| TMEM270transmembrane protein 270 | Soms (5–29%) | In 1 aandoening |
| VPS37DVPS37D subunit of ESCRT-I | Soms (5–29%) | In 1 aandoening |
| ZMYM2zinc finger MYM-type containing 2 | Soms (5–29%) | In 1 aandoening |
| ALDH3A2aldehyde dehydrogenase 3 family member A2 | Zelden (1–4%) | In 1 aandoening |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Zelden (1–4%) | In 1 aandoening |
| ALPLalkaline phosphatase, biomineralization associated | Niet vastgelegd | In 2 aandoeningen |
| CRLF1cytokine receptor like factor 1 | Niet vastgelegd | In 1 aandoening |
| GALNSgalactosamine (N-acetyl)-6-sulfatase | Niet vastgelegd | In 1 aandoening |
| GLB1galactosidase beta 1 | Niet vastgelegd | In 1 aandoening |
| KLK4kallikrein related peptidase 4 | Niet vastgelegd | In 1 aandoening |
| LAMC2laminin subunit gamma 2 | Niet vastgelegd | In 1 aandoening |
| MAPRE2microtubule associated protein RP/EB family member 2 | Niet vastgelegd | In 1 aandoening |
| OFD1OFD1 centriole and centriolar satellite protein | Niet vastgelegd | In 1 aandoening |
| PLECplectin | Niet vastgelegd | In 1 aandoening |
| SGMS2sphingomyelin synthase 2 | Niet vastgelegd | In 1 aandoening |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Niet vastgelegd | In 1 aandoening |
| TNFSF11TNF superfamily member 11 | Niet vastgelegd | In 1 aandoening |
| TRPS1transcriptional repressor GATA binding 1 | Niet vastgelegd | In 1 aandoening |
| UBE3Bubiquitin protein ligase E3B | Niet vastgelegd | In 1 aandoening |
| VDRvitamin D receptor | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken